A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
Clinical trial NCT00545233 · COMPLETED
Trial details
- NCT number
- NCT00545233
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-12-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.